SICAGEN INDIA LTD.

Sicagen India Ltd has announced the closure of its trading window for designated persons and their immediate relatives. This closure is effective from July 1, 2026, and will remain in effect until 48 hours after the declaration of the unaudited financial results (standalone and consolidated) for the quarter ended June 30, 2026. This measure is in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015, and the company's internal code of conduct. The specific date for the board meeting to approve these financial results will be communicated separately.

Twinshield Consultants Pvt Ltd has acquired 15,45,500 equity shares, representing 3.90% of the total share capital, in Sicagen India Limited through an off-market transaction. This acquisition, made at the prevailing market rate, increases Twinshield Consultants' holding as part of the promoter group. Following the transaction, their total shareholding in Sicagen India now stands at 84,48,134 shares, or 21.34% of the company's equity. The transaction was executed on June 19, 2026.

South India Travels Private Limited, a promoter group entity, has sold 15,45,500 equity shares, representing 3.90% of the total share capital, in Sicagen India Limited. The transaction was conducted off-market at the prevailing market rate. Following the sale, South India Travels' holding in Sicagen India has reduced from 4.90% to 1.00%. This disclosure is made in compliance with SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Sicagen India Ltd announced changes in senior management. Prasanna Joshi has been appointed as an additional director and subsequently as a Whole-time Director, subject to shareholder approval. Nandakumar Varma resigned from the Whole-Time Directorship. The Board recommended a 10% equity dividend (Re. 1 per share) for FY 2025-26, pending shareholder approval. K R Jaikumar was designated as Senior Management Personnel, while D. Sivakumar ceased to be at SMP level. Venkatesh & Co. was appointed as Internal Auditors for FY 2026-27, and J. Karthikeyan & Associates was re-appointed as Cost Auditor, subject to shareholder approval. The board also approved the audited financial results for the quarter and year ended March 31, 2026.

Mr. Nandakumar Varma resigned from his position as Whole-Time Director of Sicagen India Ltd, effective at the closure of business hours on May 13, 2026, citing personal reasons and other commitments. The Board of Directors approved the audited financial results for the quarter and year ended March 31, 2026, and recommended a 10% equity dividend (₹1 per share) for FY 2025-26, subject to shareholder approval. Mr. Prasanna Joshi was appointed as an additional director and subsequently as a Whole-time Director. Mr. K R Jaikumar was designated as Senior Management Personnel, while Mr. D. Sivakumar ceased to be at SMP level. M/s. Venkatesh & Co. were appointed as Internal Auditors for FY 2026-27.

Sicagen India Ltd's board meeting on May 13, 2026, approved audited financial results for the year ended March 31, 2026, and recommended a 10% equity dividend (₹1 per share), subject to shareholder approval. Prasanna Joshi was appointed as an additional director and subsequently as a Whole-time Director, while Nandakumar Varma resigned from his Whole-Time Directorship. K R Jaikumar was designated as Senior Management Personnel, and Venkatesh & Co. were appointed as Internal Auditors for FY 2026-27.

The Board of Directors of Sicagen India Ltd, in its meeting held on May 13, 2026, recommended an equity dividend of 10% (₹1.00 per share) on the equity capital for the financial year 2025-26, subject to shareholder approval. The board also approved the audited financial results for the quarter and year ended March 31, 2026. Additionally, Mr. Prasanna Joshi was appointed as an additional director and subsequently as a Whole-time Director, while Mr. Nandakumar Varma resigned from his Whole-Time Directorship. Mr. K R Jaikumar was designated as Senior Management Personnel, and M/s. Venkatesh & Co. were appointed as Internal Auditors.

Sicagen India Ltd's board approved audited financial results for the quarter and year ended March 31, 2026, recommending a 10% equity dividend (₹1 per share) for FY26, subject to shareholder approval. The board also appointed Mr. Prasanna Joshi as an additional director and subsequently as a Whole-time Director, following Mr. Nandakumar Varma's resignation. Additionally, Mr. K R Jaikumar was designated as Senior Management Personnel, while Mr. D. Sivakumar ceased to be at SMP level. M/s. Venkatesh & Co. were appointed as Internal Auditors, and M/s. J. Karthikeyan & Associates were re-appointed as Cost Auditor.

Sicagen India Ltd's board approved audited financial results for the quarter and year ended March 31, 2026, recommending a 10% equity dividend (Re. 1 per share) subject to shareholder approval. Prasanna Joshi was appointed as an additional and Whole-time Director, while Nandakumar Varma resigned from his Whole-Time Directorship. K R Jaikumar was designated as Senior Management Personnel, and Venkatesh & Co. were appointed as Internal Auditors for FY2026-27.

Sicagen India Ltd has scheduled a Board of Directors meeting on May 13, 2026, to consider and approve the audited financial results (standalone & consolidated) for the quarter and year ended March 31, 2026. The board will also consider recommending an equity dividend, if any, for the financial year 2025-26. The trading window for dealing in the company’s equity shares by designated persons and their immediate relatives remains closed from April 1, 2026, until 48 hours after the declaration of the audited financial results.